SMART represents a paradigm shift in the approach to asthma treatment. What is it? And what’s the evidence?
OSA is common, so why is there insufficient evidence to screen for it?
Pulmonary hypertension is underdiagnosed, and frequently missed. What should we be looking for?
Today’s spotlight on racism in medicine focuses on spirometry.
Asthma is a *breath-taking* topic with different guidelines shedding light on classification of severity and management. Let’s get to it.
There are MANY inhalers out there. Do you feel comfortable explaining to your patients how to use theirs correctly? If not, then this is the post for you as our favorite clinical pharmacist teaches us how to use each type!
What are the focuses of the updated NAEPP guidelines for asthma? What are the recommended changes in ICS use? And what’s the SMART thing to do?
How do the 2020 GINA guidelines differ from the 2007 NAEPP guidelines in outpatient management of asthma? How can we predict the likelihood of asthma in kids <5 years-old? How many patients use their inhalers correctly?
What’s the NNT for systemic steroids to avoid 1 hospitalization for asthma exacerbations? Are short courses of systemic steroids associated with harm?
What interventions decrease mortality in COPD management? What is the Anthonisen criteria? Did you know there are COPD action plans?